We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
Read MoreHide Full Article
Did you analyze how Staar Surgical (STAA - Free Report) fared in its international operations for the quarter ending June 2024? Given the widespread global presence of this maker of implantable lenses, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.
The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm's potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
Our review of STAA's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.
The company's total revenue for the quarter stood at $99.01 million, increasing 7.3% year over year. Now, let's delve into STAA's international revenue breakdown to gain insights into the significance of its operations beyond home turf.
A Closer Look at STAA's Revenue Streams Abroad
Other International generated $20.33 million in revenues for the company in the last quarter, constituting 20.5% of the total. This represented a surprise of +21.82% compared to the $16.69 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other International accounted for $23.42 million (30.3%), and in the year-ago quarter, it contributed $18.21 million (19.7%) to the total revenue.
Japan accounted for 10.0% of the company's total revenue during the quarter, translating to $9.89 million. Revenues from this region represented a surprise of +18.53%, with Wall Street analysts collectively expecting $8.34 million. When compared to the preceding quarter and the same quarter in the previous year, Japan contributed $10.46 million (13.5%) and $8.42 million (9.1%) to the total revenue, respectively.
Of the total revenue, $63.4 million came from China during the last fiscal quarter, accounting for 64.0%. This represented a surprise of -3.12% as analysts had expected the region to contribute $65.44 million to the total revenue. In comparison, the region contributed $38.55 million, or 49.8%, and $61.34 million, or 66.5%, to total revenue in the previous and year-ago quarters, respectively.
Projected Revenues in Foreign Markets
Wall Street analysts expect Staar Surgical to report a total revenue of $87.14 million in the current fiscal quarter, which suggests an increase of 8.5% from the prior-year quarter. Revenue shares from Other International, Japan and China are predicted to be 21.9%, 10.5% and 62.9%, corresponding to amounts of $19.08 million, $9.16 million and $54.8 million, respectively.
For the full year, the company is projected to achieve a total revenue of $341.94 million, which signifies a rise of 6.1% from the last year. The share of this revenue from various regions is expected to be: Other International at 23% ($78.56 million), Japan at 10.9% ($37.36 million) and China at 59.9% ($204.83 million).
Key Takeaways
Staar Surgical's leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.
With the increasing intricacies of global interdependence and geopolitical strife, Wall Street analysts meticulously observe these patterns, especially for companies with an international footprint, to tweak their forecasts of earnings. Importantly, several additional factors, such as a company's domestic market status, also impact these earnings forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
With an impressive externally audited track record, our proprietary stock rating tool - the Zacks Rank - harnesses the power of earnings estimate revisions and serves as an effective indicator of a stock's near-term price performance.
Image: Bigstock
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
Did you analyze how Staar Surgical (STAA - Free Report) fared in its international operations for the quarter ending June 2024? Given the widespread global presence of this maker of implantable lenses, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.
The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm's potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
Our review of STAA's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.
The company's total revenue for the quarter stood at $99.01 million, increasing 7.3% year over year. Now, let's delve into STAA's international revenue breakdown to gain insights into the significance of its operations beyond home turf.
A Closer Look at STAA's Revenue Streams Abroad
Other International generated $20.33 million in revenues for the company in the last quarter, constituting 20.5% of the total. This represented a surprise of +21.82% compared to the $16.69 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other International accounted for $23.42 million (30.3%), and in the year-ago quarter, it contributed $18.21 million (19.7%) to the total revenue.
Japan accounted for 10.0% of the company's total revenue during the quarter, translating to $9.89 million. Revenues from this region represented a surprise of +18.53%, with Wall Street analysts collectively expecting $8.34 million. When compared to the preceding quarter and the same quarter in the previous year, Japan contributed $10.46 million (13.5%) and $8.42 million (9.1%) to the total revenue, respectively.
Of the total revenue, $63.4 million came from China during the last fiscal quarter, accounting for 64.0%. This represented a surprise of -3.12% as analysts had expected the region to contribute $65.44 million to the total revenue. In comparison, the region contributed $38.55 million, or 49.8%, and $61.34 million, or 66.5%, to total revenue in the previous and year-ago quarters, respectively.
Projected Revenues in Foreign Markets
Wall Street analysts expect Staar Surgical to report a total revenue of $87.14 million in the current fiscal quarter, which suggests an increase of 8.5% from the prior-year quarter. Revenue shares from Other International, Japan and China are predicted to be 21.9%, 10.5% and 62.9%, corresponding to amounts of $19.08 million, $9.16 million and $54.8 million, respectively.For the full year, the company is projected to achieve a total revenue of $341.94 million, which signifies a rise of 6.1% from the last year. The share of this revenue from various regions is expected to be: Other International at 23% ($78.56 million), Japan at 10.9% ($37.36 million) and China at 59.9% ($204.83 million).
Key Takeaways
Staar Surgical's leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.With the increasing intricacies of global interdependence and geopolitical strife, Wall Street analysts meticulously observe these patterns, especially for companies with an international footprint, to tweak their forecasts of earnings. Importantly, several additional factors, such as a company's domestic market status, also impact these earnings forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
With an impressive externally audited track record, our proprietary stock rating tool - the Zacks Rank - harnesses the power of earnings estimate revisions and serves as an effective indicator of a stock's near-term price performance.
At present, Staar Surgical holds a Zacks Rank #4 (Sell). This ranking implies that its near-term performance might underperform the overall market movement. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Reviewing Staar Surgical's Recent Stock Price Trends